Neogen Corporation (NEOG) Stock Forecast

NASDAQ: NEOGAnalyst ratings, price target and estimates.

NEOG analyst forecast

as of October 18, 2026
Analyst consensus
Buy
4.00 / 5 from 4 analysts
Price target
$14.00
average of analyst targets
Upside to target
+18.5%
from the latest close
Next earnings
—
52-week range
$5.41 – $13.98

NEOG analyst ratings

4 analysts
Strong buy
125%
Buy
250%
Hold
125%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

NEOG price target

Price $11.81Target $14.00
52-week low $5.4152-week high $13.98

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

NEOG earnings per share estimates

Neogen Corporation EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Nov '26)$0.08$0.06$0.10$0.10−23.3%3
Next quarter (Feb '27)$0.08$0.06$0.10$0.09−14.8%3
Current fiscal year (FY2027)$0.32$0.30$0.36$0.32+1.0%3
Next fiscal year (FY2028)$0.40$0.39$0.43$0.32+24.7%3

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

NEOG revenue estimates

Neogen Corporation revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Nov '26)$224.8M$223.2M$229.0M+0.0%4
Next quarter (Feb '27)$214.4M$213.1M$215.3M+1.5%4
Current fiscal year (FY2027)$886.6M$882.1M$889.2M+1.9%4
Next fiscal year (FY2028)$874.5M$828.0M$933.7M−1.4%4

NEOG EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

NEOG revenue: reported and forecast

Reported revenueEstimate (average; low–high)

NEOG EPS estimate revisions

Neogen Corporation EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Nov '26)$0.10$0.09$0.09$0.09$0.08−20.7%0 up · 0 down
Next quarter (Feb '27)$0.07$0.07$0.07$0.07$0.08+15.0%0 up · 0 down
Current fiscal year (FY2027)$0.30$0.31$0.31$0.31$0.32+7.8%0 up · 0 down
Next fiscal year (FY2028)$0.42$0.38$0.38$0.38$0.40−4.0%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

NEOG earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; NEOG beat in 7 of 12.

What analysts expect from NEOG

4 analysts cover Neogen; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $14.00, 18.5% above the latest close of $11.81. Analysts expect earnings of $0.32 per share for FY2027, +1.0% from a year earlier. For FY2028 the average estimate is $0.40 per share on revenue of $874.5 million. Neogen beat the EPS estimate in 7 of the last 12 quarters.

Related: NEOG income statement, NEOG key metrics, NEOG chart. See the NEOG stock overview for the latest quote and news.

NEOG forecast FAQ

What is Neogen's price target?

The average analyst price target for Neogen is $14.00, 18.5% above the latest close of $11.81.

Is Neogen a buy, hold or sell?

Of 4 analysts covering Neogen, 1 rate it a strong buy, 2 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Neogen's EPS forecast?

Analysts forecast $0.32 per share for FY2027 (range $0.30 to $0.36); for FY2028 the estimate is $0.40.

What is Neogen's revenue forecast?

The average revenue estimate for FY2027 is $886.6 million, growth of 1.9%; for FY2028 it is $874.5 million.

Does Neogen usually beat earnings estimates?

Neogen reported EPS at or above the analyst estimate in 7 of the last 12 quarters.

Medical Devices: forecast